Skip to main content Scroll Top
Beyond-the-brain’ strategy: a new photobiomodulation technique produces a neuroprotective effect in a mouse model of Alzheimer’s disease by synergistic mechanisms when targeting brain and guts
Most Viewed Posts
Clear Filters
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
1 April 2026
REGEnLIFE cures inflammatory brain diseases with light
REGEnLIFE cures inflammatory brain diseases with light
21 February 2025
Photobiomodulation: light to treat Alzheimer’s disease
Photobiomodulation: light to treat Alzheimer’s disease
2 July 2024
10 September 2019

Beyond-the-brain’ strategy: a new photobiomodulation technique produces a neuroprotective effect in a mouse model of Alzheimer’s disease by synergistic mechanisms when targeting brain and guts

International Brain Stimulation Conference, 2019, Vancouver
Read the article

Guillaume Blivet, Laura Auboyer, Johann Meunier, Laura Ceolin, François J. Roman, Rémy Burcelin, Jacques Touchon.

Share this article